Saturday, January 24, 2009

Stem Cell Clinical Trials

The FDA has approved clinical trials with embryonic stem cells. Researchers with Geron Corporation will test safety and efficacy of stem cells in spinal cord injury patients in trials likely starting this summer. The first clinical trials represent a big step forward in stem cell research, research that has been significantly hampered by the Bush administration. Geron CEO Thomas Okarma remarked that Bush restrictions had "devastated the field".

Another biotech company ReNeuron has been approved to begin stem cell clinical trials in Britain. Their studies will focus on stroke victims.

(image credit: embryonic stem cell, REUTERS/University of Wisconsin)